利用 LATITUDE 对疑似 COVID19 肺部感染的可重现传感器模式：病例报告及文献复习。
A reproducible sensor pattern to suspect COVID19 pulmonary infection with LATITUDE. Case report and literature review.
机构信息
Cardiovascular Department, Fondazione Poliambulanza, Brescia (IT), Brescia, Italy.
出版信息
Pacing Clin Electrophysiol. 2022 Mar;45(3):425-430. doi: 10.1111/pace.14469. Epub 2022 Feb 23.
Abstract
A 78 year-old patient with postischaemic dilated cardiomyopathy and severely reduced ejection fraction was implanted with a Boston Scientific RESONATE X4 CRT-D and followed by LATITUDE remote monitoring platform. From the end of January to the end of March 2021 he was hospitalized for COVID19 pneumonia followed by two episodes of acute heart decompensation with bilateral pleural effusion. We remotely followed the patient and identified a typical Heart Logic sensor pattern linked to the COVID19 pneumonia, different from the one linked to the heart failure (HF). We eventually made a literature review on the topic.
摘要
一位 78 岁的患者患有缺血性扩张型心肌病和射血分数严重降低，植入了波士顿科学公司的 RESONATE X4 CRT-D，并使用了 LATITUDE 远程监测平台。从 2021 年 1 月底到 3 月底，他因 COVID19 肺炎住院，随后出现两次急性心脏失代偿伴双侧胸腔积液。我们远程随访了该患者，并识别出与 COVID19 肺炎相关的典型 Heart Logic 传感器模式，与心力衰竭（HF）相关的模式不同。我们最终对该主题进行了文献回顾。
相似文献
1
A reproducible sensor pattern to suspect COVID19 pulmonary infection with LATITUDE. Case report and literature review.利用 LATITUDE 对疑似 COVID19 肺部感染的可重现传感器模式：病例报告及文献复习。
Pacing Clin Electrophysiol. 2022 Mar;45(3):425-430. doi: 10.1111/pace.14469. Epub 2022 Feb 23.
2
Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.射血分数保留或降低的急性失代偿性心力衰竭住院患者的心力衰竭病因及预后
Am J Cardiol. 2016 Dec 15;118(12):1881-1887. doi: 10.1016/j.amjcard.2016.08.080. Epub 2016 Sep 15.
3
Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice.肺部超声作为一种转化方法，用于无创评估心力衰竭小鼠的射血分数降低或保留。
Cardiovasc Res. 2017 Aug 1;113(10):1113-1123. doi: 10.1093/cvr/cvx090.
4
Pediatric Dilated Cardiomyopathy Patients Do Not Meet Traditional Cardiac Resynchronization Criteria.小儿扩张型心肌病患者不符合传统心脏再同步治疗标准。
J Cardiovasc Electrophysiol. 2015 Aug;26(8):885-889. doi: 10.1111/jce.12690. Epub 2015 May 25.
5
Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report.多传感器 HeartLogic 算法在心力衰竭监测中的初步经验：回顾性病例系列报告。
ESC Heart Fail. 2019 Apr;6(2):308-318. doi: 10.1002/ehf2.12394. Epub 2019 Jan 11.
6
7
[Early warning system for pulmonary fluid status monitoring in terminal heart failure].[终末期心力衰竭肺液体状态监测预警系统]
Dtsch Med Wochenschr. 2007 Mar 16;132(11):555-9. doi: 10.1055/s-2007-970376.
8
Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.无线肺动脉压监测指导治疗，以减少射血分数保留的心力衰竭患者的失代偿情况。
Circ Heart Fail. 2014 Nov;7(6):935-44. doi: 10.1161/CIRCHEARTFAILURE.113.001229. Epub 2014 Oct 6.
9
A 29-Year-Old Man with COVID-19 Pneumonia, Heart Failure-Reduced Ejection Fraction, and Atrial Fibrillation with a Father and 2 Grandparents Who Were Positive for SARS-CoV-2 Infection.一位 29 岁男性，因 COVID-19 肺炎、心力衰竭伴射血分数降低和心房颤动入院，其父亲和 2 位祖父母均为 SARS-CoV-2 感染阳性。
Am J Case Rep. 2021 Jul 23;22:e933163. doi: 10.12659/AJCR.933163.
10
The influence of obstructive sleep breathing disturbances on echocardiographic and pulmonary haemodynamic parameters in patients with dilated cardiomyopathy.阻塞性睡眠呼吸障碍对扩张型心肌病患者超声心动图和肺血流动力学参数的影响。
Kardiol Pol. 2016;74(2):135-41. doi: 10.5603/KP.a2015.0140. Epub 2015 Jul 23.
引用本文的文献
1
Analysis of the value of infrared thermal imaging technology in the diagnosis of emergency pulmonary infections.红外热成像技术在急诊肺部感染诊断中的价值分析
Sci Rep. 2025 Aug 10;15(1):29278. doi: 10.1038/s41598-025-15123-4.
本文引用的文献
1
Multiparameter diagnostic sensor measurements in heart failure patients presenting with SARS-CoV-2 infection.在因 SARS-CoV-2 感染而出现心力衰竭的患者中，多参数诊断传感器测量。
ESC Heart Fail. 2021 Oct;8(5):4026-4036. doi: 10.1002/ehf2.13500. Epub 2021 Jun 28.
2
Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19.心脏病、心血管药物和心脏事件的存在对 COVID-19 结局的影响。
Cardiol J. 2021;28(3):360-368. doi: 10.5603/CJ.a2021.0034. Epub 2021 Apr 12.
3
Use of a novel implantable cardioverter-defibrillator multisensor algorithm for heart failure monitoring in a COVID-19 patient: A case report.新型植入式心脏复律除颤器多传感器算法在一名COVID-19患者心力衰竭监测中的应用：病例报告
Clin Case Rep. 2021 Jan 28;9(3):1178-1182. doi: 10.1002/ccr3.3721. eCollection 2021 Mar.
4
Novel findings of respiratory rate increases using the multisensor HeartLogic heart failure monitoring algorithm in COVID-19-positive patients: a case series.使用多传感器心脏逻辑心力衰竭监测算法在新冠病毒检测呈阳性患者中发现呼吸频率增加的新情况：病例系列
Eur Heart J Case Rep. 2021 Feb 20;5(2):ytab067. doi: 10.1093/ehjcr/ytab067. eCollection 2021 Feb.
5
Case Reports of Implantable Cardiac Device Physiologic Sensor Changes in Subjects with Coronavirus Disease-2019 Infection.新型冠状病毒肺炎感染者植入性心脏装置生理性传感器变化的病例报告。
J Card Fail. 2021 Mar;27(3):373-378. doi: 10.1016/j.cardfail.2020.12.019. Epub 2020 Dec 29.
6
A Steep Increase in the HeartLogic Index Predicts COVID-19 Disease in an Advanced Heart Failure Patient.HeartLogic指数急剧升高预示晚期心力衰竭患者患COVID-19疾病。
Case Rep Cardiol. 2020 Jul 11;2020:8896152. doi: 10.1155/2020/8896152. eCollection 2020.
7
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
8
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
9
CorVue algorithm efficacy to predict heart failure in real life: Unnecessary and potentially misleading information?CorVue算法在现实生活中预测心力衰竭的有效性：不必要且可能具有误导性的信息？
Pacing Clin Electrophysiol. 2018 Jun 1. doi: 10.1111/pace.13399.
10
An improved algorithm calculated from intrathoracic impedance can precisely diagnose preclinical heart failure events: Sub-analysis of a multicenter MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) trial study.一种基于胸内阻抗计算出的改进算法能够精确诊断临床前心力衰竭事件：一项多中心MOMOTARO（优化容积警报监测与管理以减少心力衰竭住院率）试验研究的亚分析。
J Cardiol. 2017 Nov;70(5):425-431. doi: 10.1016/j.jjcc.2017.05.004. Epub 2017 Jun 30.
Zotero 插件